⌘K

Kezar Life Sciences, Inc. (KZR)

$0.58 1.08% $0.00 Healthcare

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and immunology. The company was incorporated in 2015 and is based in South San Francisco, California.

Market cap

$42.51M

CEO

Mr. John Franklin Fowler

Full time employees

56.00

Headquarters

South San Francisco, CA

IPO Date

Jun 21, 2018

Price-to-earnings (PE) Ratio

-0.43

Earnings-per-share (EPS)

$-1.35

Cash ratio (TTM)

1.62

Current ratio (TTM)

9.58

Net profit margin (TTM)

-6,270.23%

PE ratio (TTM)

-0.42

PEG ratio (TTM)

-0.07

Price-to-book ratio (TTM)

0.28

Price-to-sales ratio (TTM)

26.69

Quick ratio (TTM)

9.58

Return on assets (TTM)

-54.78%

Return on equity (TTM)

-54.50%

Similar stocks (18)

Revolution Medicines, Inc.

RVMD

$46.18 4.81% $2.12

Uptrend

Kymera Therapeutics, Inc.

KYMR

$49.03 5.58% $2.59

Uptrend

Keros Therapeutics, Inc.

KROS

$57.32 2.89% $1.61

Neutral

Nurix Therapeutics, Inc.

NRIX

$25.06 1.29% $0.32

Uptrend

Cullinan Oncology, Inc.

CGEM

$17.94 4.12% $0.71

Downtrend

Stoke Therapeutics, Inc.

STOK

$15.14 -0.53% $-0.08

Uptrend

Foghorn Therapeutics Inc.

FHTX

$9.67 1.15% $0.11

Uptrend

Larimar Therapeutics, Inc.

LRMR

$7.14 4.23% $0.29

Downtrend

Lyell Immunopharma, Inc.

LYEL

$1.56 15.56% $0.21

Downtrend

Monte Rosa Therapeutics, Inc.

GLUE

$6.25 5.04% $0.30

Neutral

Nkarta, Inc.

NKTX

$5.38 2.09% $0.11

Downtrend

Design Therapeutics, Inc.

DSGN

$5.86 3.90% $0.22

Uptrend

Shattuck Labs, Inc.

STTK

$3.70 1.37% $0.05

Downtrend

Century Therapeutics, Inc.

IPSC

$1.70 3.03% $0.05

Downtrend

Werewolf Therapeutics, Inc.

HOWL

$2.40 8.11% $0.18

Downtrend

Ikena Oncology, Inc.

IKNA

$1.71 3.01% $0.05

Neutral

Surrozen, Inc.

SRZN

$8.15 1.75% $0.14

Downtrend

Bolt Biotherapeutics, Inc.

BOLT

$0.63 1.35% $0.00

Downtrend

ETF Exposure (10)

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.43 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.42 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.42 -0.26% $-0.13

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.13 -0.25% $-0.24

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.11 -0.25% $-0.24

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend

Downtrend

Similar stocks (18)

Revolution Medicines, Inc.

RVMD

$46.18 4.81% $2.12

Uptrend

Kymera Therapeutics, Inc.

KYMR

$49.03 5.58% $2.59

Uptrend

Keros Therapeutics, Inc.

KROS

$57.32 2.89% $1.61

Neutral

Nurix Therapeutics, Inc.

NRIX

$25.06 1.29% $0.32

Uptrend

Cullinan Oncology, Inc.

CGEM

$17.94 4.12% $0.71

Downtrend

Stoke Therapeutics, Inc.

STOK

$15.14 -0.53% $-0.08

Uptrend

Foghorn Therapeutics Inc.

FHTX

$9.67 1.15% $0.11

Uptrend

Larimar Therapeutics, Inc.

LRMR

$7.14 4.23% $0.29

Downtrend

Lyell Immunopharma, Inc.

LYEL

$1.56 15.56% $0.21

Downtrend

Monte Rosa Therapeutics, Inc.

GLUE

$6.25 5.04% $0.30

Neutral

Nkarta, Inc.

NKTX

$5.38 2.09% $0.11

Downtrend

Design Therapeutics, Inc.

DSGN

$5.86 3.90% $0.22

Uptrend

Shattuck Labs, Inc.

STTK

$3.70 1.37% $0.05

Downtrend

Century Therapeutics, Inc.

IPSC

$1.70 3.03% $0.05

Downtrend

Werewolf Therapeutics, Inc.

HOWL

$2.40 8.11% $0.18

Downtrend

Ikena Oncology, Inc.

IKNA

$1.71 3.01% $0.05

Neutral

Surrozen, Inc.

SRZN

$8.15 1.75% $0.14

Downtrend

Bolt Biotherapeutics, Inc.

BOLT

$0.63 1.35% $0.00

Downtrend

ETF Exposure (10)

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.43 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.42 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.42 -0.26% $-0.13

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.13 -0.25% $-0.24

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.11 -0.25% $-0.24

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend